CapitalBio Tests Certified for Dx Use in China, Europe | GenomeWeb

NEW YORK (GenomeWeb News) – CapitalBio has been cleared by the Chinese government to use its microarray-based diagnostic tests for autoimmine diseases and it has certified with the CE mark tests for tuberculosis testing in Europe, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.